Chapters, Reviews, and Monographs

  1. Was H., Borkowska A., Bagues A., Tu L., Liu J.Y.H., Lu Z., Rudd J.A., Nurgali K., Abalo R. (2022) Mechanisms of chemotherapy-induced neurotoxicity. Frontiers in Pharmacology. 
  2. Andrew, P.L.R, Cai, W.G., Rudd, J.A. & Sanger, G.J. (2020). COVID‐19, nausea, and vomiting. Journal of Gastroenterology and Hepatology, doi: 10.1111/jgh.15261
  3. Peng, D., Liu, Y.H., Sukasem, A., Qian, A., Calder, S. & Rudd, J.A. (2020). Recent progress in electrophysiology and motility mapping of the gastrointestinal tract using multi-channel devices, Journal of the Royal Society of New Zealand, 50(2) 316-330.
  4. Rudd, J.A., Nalivaiko E., Matsuki, N., Wan C., & Andrews, P.L.R. (2015). The involvement of TRPV1 in emesis and anti-emesis. Temperature, 2, 258-276.
  5. Andrew, P.L.R., & Rudd, J.A. (2015). The physiology and pharmacology of nausea and vomiting induced by anti-cancer chemotheraphy in humans. In: Management of chemotherapy-induced nausea and vomiting: new agents and new uses of current agents, R. Navari, Editor. Springer Health Care Publishers: London, England.
  6. Nalivaiko, E., Rudd, J. A., & So, R. (2014). Motion sickness, nausea and thermoregulation: the "toxic" hypothesis. Temperature, 1, 164-171.
  7. Johnston, K.D., Lu, Z., & Rudd, J.A. (2014). Looking beyond 5-HT3 receptors: a review of the wider role of serotonin in the pharmacology of nausea and vomiting. European Journal of Pharmacology, 722, 13-25.
  8. Holmes, A.M., Rudd, J.A., Tattersall, F.D., Aziz, Q., & Andrews, P.L.R. (2009). Opportunities for the replacement of animals in the study of nausea and vomiting. British Journal of Pharmacology 157:865-880
  9. Eds. D.A. Christe and E.M. Tansey (2007). Discovery, use and impact of platinum salts as chemotherapy agents for cancer. In: Wellcome Witness to Twentieth Century Medicine. Wellcome Trust Centre for the History of Medicine. 30, 1-117.
  10. Rudd, J.A. & Andrews, P.L.R. (2004). Mechanisms of acute, delayed and anticipatory emesis induced by anti-cancer therapies. In: Management of nausea and vomiting in cancer and cancer treatment Ed. P. Hesketh. Jones and Barlett Publisers Inc., London, pp 15-66.
  11. Andrews, P.L.R. & Rudd, J.A. (2004). The role of tachykinins and the NK1 receptor in nausea and emesis. In: Tachykinins. Ed. Holzer, P, Springer Verlag, USA. Handbook of Experimental Pharmacology, 164, 359-441.
  12. Rudd, J.A. Cheng, C.H.K. & Naylor, R.J. (1995).  The effect of alteration of 5-HT synthesis on cisplatin (10 mg/kg)-induced emesis in the ferret during a 24 h observation period. In:  Serotonin and the scientific basis of anti-emetic therapy.  Eds.  D.J.M. Reynolds, P.L.R. Andrews & C.J. Davis, Oxford Clinical Communications, Oxford, pp248.
  13. Rudd, J.A. & Naylor, R.J. (1995).  Opioid receptor involvement in emesis and anti-emesis.  In:  Serotonin and the scientific basis of anti-emetic therapy.  Eds.  D.J.M. Reynolds, P.L.R. Andrews & C.J. Davis, Oxford Clinical Communications, Oxford, pp208-221.
  14. Costall, B., Naylor, R.J. & Rudd, J.A. (1993).  The antiemetic properties of 5-HT3 receptor antagonists.  In: Serotonin, from cell biology to pharmacology and therapeutics.  Eds.  P.M. Vanhoutte, P.R. Saxena, R. Paoletti, N. Brunello & A.S., Jackson, Kluwer Academic Publishers, Netherlands, pp165-170.
  15. Rudd, J.A. & Naylor, R.J. (1992).  Morphine-induced emesis in the ferret.  In: Mechanism and Control of emesis.  Eds. A. L. Bianchi, L. Grelot, A.D. Miller, G.L. King, Collogue Inserm, John Libby, Eurotext Ltd., France 223: pp351-352.
  16. Naylor, R.J. & Rudd, J.A. (1992).  Mechanism of chemotherapy-induced vomiting: Involvement of 5-HT3 receptors.  In:  Mechanism and Control of Emesis.  Eds. A. L. Bianchi, L. Grelot, A.D. Miller, G.L., King, Collogue Inserm, John Libby, Eurotext Ltd., France 223:  pp115-127.